Search all trials

Find therapies in clinical trials near you – page 34

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Actinic keratosis

Not recruiting

Registered drugNo placebo

Study on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Diclofenac Sodium

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Age-related macular degeneration

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

Registered drugNo placebo

Germany

Participants:65+ years
Substances:Ranibizumab

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

Investigational

Germany

Participants:0–17 years
Substances:Bimekizumab

Contact Research Centre

Short stature+3

Not recruiting

Registered drugNo placebo

Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Somapacitan

Contact Research Centre

Glioblastoma

Not recruiting

InvestigationalNo placebo

Study of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pegargiminase

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Registered drugNo placebo

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Laparotomy

Not recruiting

Investigational

Study on Oral Lidocaine for Reducing Gastrointestinal Issues in Patients After Abdominal Surgery

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Lidocaine Hydrochloride Monohydrate

Contact Research Centre

Lupus nephritis

Not recruiting

Registered drug

Study on Zetomipzomib for Patients with Active Lupus Nephritis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Methylprednisolone

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hydrocortisone

Contact Research Centre

Find therapies in clinical trials near you – page 34

469 trials match your criteria

Multiple sclerosis

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Gastroenteropancreatic neuroendocrine tumour disease

Study of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Actinic keratosis

Study on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp

Breast cancer+1

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Age-related macular degeneration

Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

Psoriasis

Study on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

Short stature+3

Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

Glioblastoma

Study of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma

Gastrooesophageal cancer

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Laparotomy

Study on Oral Lidocaine for Reducing Gastrointestinal Issues in Patients After Abdominal Surgery

Lupus nephritis

Study on Zetomipzomib for Patients with Active Lupus Nephritis

Dermatitis atopic

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.